Clinical Trial Update: A Dose Finding Study of Topically Applied I-020201 as an Adjunct to Good Standard-of-care in Patients With Chronic Diabetic Foot Ulcers [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding study tested topically applied I-020201 as an adjunct to standard care in patients with chronic diabetic foot ulcers; the trial has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• I-020201

Snippet

Sponsor: Kuros Biosurgery AG | Conditions: Diabetic Foot Ulcer | Phase 2 | Status: COMPLETED